LobbyingEndo USA, Inc., A Mallinckrodt-Endo Company lobbying by quarter
Endo USA, Inc., A Mallinckrodt-Endo Company's latest lobbying report covers Q1 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $40K. Its first report covers Q1 2018; the issues it reports most are Health Issues and Pharmacy.
Endo USA, Inc., A Mallinckrodt-Endo Company
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $40K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2018
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2018 | $0 | 1 |
| Q2 2018 | $0 | 1 |
| Q3 2018 | $0 | 1 |
| Q4 2018 | $140K | 1 |
| Q1 2019 | $70K | 1 |
| Q2 2019 | $120K | 1 |
| Q3 2019 | $70K | 1 |
| Q4 2019 | $70K | 1 |
| Q1 2020 | $90K | 2 |
| Q2 2020 | $90K | 2 |
| Q3 2020 | $90K | 2 |
| Q4 2020 | $90K | 2 |
| Q1 2021 | $90K | 2 |
| Q2 2021 | $90K | 2 |
| Q3 2021 | $90K | 2 |
| Q4 2021 | $90K | 2 |
| Q1 2022 | $90K | 2 |
| Q2 2022 | $90K | 2 |
| Q3 2022 | $90K | 2 |
| Q4 2022 | $90K | 2 |
| Q1 2023 | $90K | 2 |
| Q2 2023 | $90K | 2 |
| Q3 2023 | $90K | 2 |
| Q4 2023 | $90K | 2 |
| Q1 2024 | $90K | 2 |
| Q2 2024 | $90K | 2 |
| Q3 2024 | $90K | 2 |
| Q4 2024 | $90K | 2 |
| Q1 2025 | $90K | 2 |
| Q2 2025 | $90K | 2 |
| Q3 2025 | $90K | 2 |
| Q4 2025 | $40K | 2 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$1.3M · 34 reports
- Health issues$1.1M · 38 reports
- Medicare and Medicaid$226.7K · 13 reports
- Trade$6,667 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES56 reports
- SENATE56 reports
Firms it paid
| Firm | ||
|---|---|---|
| Foley & Lardner | $2.1M | 32 quarters |
| Jeffrey J. Kimbell & Associates | $480K | 25 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRETT MEEKS | Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander | Q4 2025 |
| JARED RIFIS | Legislative Correspondent, Legislative Aide; Legislative Assistant: Sen. Harry Reid | Q4 2025 |
| JENNIFER FITZGERALD WALSH | AA; Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Asst, Program Dir, EA: House Democratic Caucus | Q4 2025 |
| JOHN HERZOG | Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President | Q4 2025 |
| JOHN R RAY | Legislative Assistant, Rep. Mike Kelly | Q4 2025 |
| KATE M. KROS | None | Q4 2025 |
| KEITH STUDDARD | Legislative Director, Rep. Marsha Blackburn | Q4 2025 |
| LAURA KEMPER | Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services | Q4 2025 |
| DENNIS ALAN CARDOZA | Member of Congress 2003 - 2012 | Q3 2025 |
| KELSEY CARLSON | Special Assistant, National Security Council; Special Assistant, International Trade Administration, Dept of Commerce; Policy Advisor, Office of the Deputy Chief of Staff, Executive Office of the President; Confidential Assistant, Dept of Commerce | Q4 2024 |
| THEODORE H BORNSTEIN | COS Rep. Aspin; COS Sen. Kohl; OSD-DOD | Q1 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 04/20for Q1 | Jeffrey J. Kimbell & Associates | Under $5,000 |
| 03/12for Q4 2024 | Jeffrey J. Kimbell & Associates | $20K |
| 03/09for Q4 2024 | Jeffrey J. Kimbell & Associates | $20K |
| 01/19for Q4 2025 | Foley & Lardner | $20K |
| 01/14for Q4 2025 | Jeffrey J. Kimbell & Associates | $20K |
| 25/10/20for Q3 2025 | Jeffrey J. Kimbell & Associates | $20K |
| 25/10/20for Q3 2025 | Foley & Lardner | $70K |
| 25/09/25for Q4 2024 | Jeffrey J. Kimbell & Associates | $20K |
| 25/07/14for Q2 2025 | Jeffrey J. Kimbell & Associates | $20K |
| 25/07/08for Q2 2025 | Foley & Lardner | $70K |
| 25/04/17for Q1 2025 | Foley & Lardner | $70K |
| 25/04/16for Q1 2025 | Jeffrey J. Kimbell & Associates | $20K |
| 25/01/20for Q4 2024 | Foley & Lardner | $70K |
| 25/01/14for Q4 2024 | Jeffrey J. Kimbell & Associates | $20K |
| 24/10/21for Q3 2024 | Foley & Lardner | $70K |
| 24/10/21for Q2 2016 | Foley & Lardner | Under $5,000 |
| 24/10/21for Q3 2024 | Jeffrey J. Kimbell & Associates | $20K |
| 24/07/15for Q2 2024 | Jeffrey J. Kimbell & Associates | $20K |
| 24/07/15for Q2 2024 | Foley & Lardner | $70K |
| 24/04/17for Q1 2024 | Jeffrey J. Kimbell & Associates | $20K |